UTHR - Company ID 0001082554
The table below shows UNITED THERAPEUTICS Corp's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.28B | $1.34B | $1.59B | $1.90B | $1.55B | $1.36B |
| Short-term investments | $874.00M | $1.43B | $1.46B | $1.42B | $1.77B | $1.62B |
| Receivables | $312.00M | $297.70M | $379.30M | $322.00M | $341.80M | $290.70M |
| Inventory | $178.30M | $176.50M | $169.20M | $165.40M | $146.70M | $136.50M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $2.87B |
| $3.49B |
| $3.83B |
| $3.94B |
| $4.00B |
| $3.62B |
| Property, plant & equipment | $1.84B | $1.56B | $1.36B | $1.30B | $1.16B | $1.09B |
| Goodwill | - | - | - | - | - | - |
| Total assets | $6.71B | $7.35B | $7.91B | $7.74B | $7.12B | $6.72B |
| Accounts payable | - | - | - | - | - | - |
| Total current liabilities | $599.10M | $546.30M | $527.10M | $721.50M | $873.40M | $832.30M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $813.10M | $760.90M | $734.40M | $936.70M | $1.02B | $1.03B |
| Retained earnings | $8.83B | $8.19B | $7.85B | $7.54B | $6.92B | $6.61B |
| Total equity | $5.90B | $6.59B | $7.17B | $6.81B | $6.10B | $5.70B |